Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Doxorubicin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00005643
What this trial is testing

Chemotherapy in Treating Patients With Sarcoma of the Uterus

Who this might be right for
Endometrial CancerSarcoma
Gynecologic Oncology Group
Not applicableActive Not RecruitingNCT01928589
What this trial is testing

Partial Irradiation and Sequential vs. Concurrent Chemo Early Breast Cancer

Who this might be right for
Breast CancerAdenocarcinoma of the Breast
Richard Zellars 81
Testing effectiveness (Phase 2)Study completedNCT02414568
What this trial is testing

Bendamustine Study in Classical Hodgkin Lymphoma Patients Over 60 Treated by Prednisone, Vinblastine and Doxorubicin

Who this might be right for
Classical Hodgkin Lymphoma
The Lymphoma Academic Research Organisation 90
Testing effectiveness (Phase 2)Study completedNCT00005991
What this trial is testing

Gemcitabine and Liposomal Doxorubicin in Treating Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 76
Not applicableUnknownNCT04654195
What this trial is testing

Study of ABCB1,SLC22A16 Drug Transporter Genes and Doxorubicin and Cyclophosphamide Toxicity in Brest Cancer Patient

Who this might be right for
Breast Cancer Patients
Damanhour University 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT04874311
What this trial is testing

Bintrafusp Alfa and Doxorubicin Hydrochloride in Treating Patients With Advanced Sarcoma

Who this might be right for
Advanced Soft-tissue SarcomaMetastatic Soft-tissue Sarcoma
Institut Bergonié 80
Post-approval studies (Phase 4)Study completedNCT03514381
What this trial is testing

Pharmacologic Interaction Between Ifosfamide and Aprepitant in Treated Patients With Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Institut Claudius Regaud 59
Testing effectiveness (Phase 2)Study completedNCT03161132
What this trial is testing

Resistant Ovarian Cancer, Olaparib and Liposomal Doxorubicin

Who this might be right for
Advanced Ovarian Cancer
Grupo Español de Investigación en Cáncer de Ovario 32
Testing effectiveness (Phase 2)Study completedNCT00574587
What this trial is testing

Trial for Locally Advanced Breast Cancer Using Vorinostat Plus Chemotherapy

Who this might be right for
Breast Cancer
Albert Einstein College of Medicine 55
Early research (Phase 1)Study completedNCT00061867
What this trial is testing

Liposomal Doxorubicin and Thermal Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Imunon
Large-scale testing (Phase 3)Study completedNCT00536393
What this trial is testing

Treatment of Disseminated High Grade Lymphoma

Who this might be right for
Lymphoma
French Innovative Leukemia Organisation 100
Not applicableNot Yet RecruitingNCT06652152
What this trial is testing

Mechanism Investigation of R-CHOP Regimen or Tucidinostat Plus R-CHOP (CR-CHOP) Regimen in the Treatment of BCL2/MYC Protein Double Expressor Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma (DLBCL)Double Expressor Lymphoma
Ruijin Hospital 400
Testing effectiveness (Phase 2)Study completedNCT00814541
What this trial is testing

PAD. ICORG 05-01, V11

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Cancer Trials Ireland 53
Testing effectiveness (Phase 2)Looking for participantsNCT05824975
What this trial is testing

Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorSoft Tissue Sarcoma (STS)+6 more
GI Innovation, Inc. 358
Testing effectiveness (Phase 2)Study completedNCT01248962
What this trial is testing

Standard Infusion Carboplatin Versus Prophylactic Extended Infusion Carboplatin in Patients With Patients With Recurrent, Ovary, Fallopian Tube, and Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer
Memorial Sloan Kettering Cancer Center 146
Testing effectiveness (Phase 2)Ended earlyNCT00903656
What this trial is testing

Lapatinib Plus Caelyx in Patients With Advanced Metastatic Breast Cancer Following Failure of Trastuzumab Therapy

Who this might be right for
Metastatic Breast Cancer
Arbeitsgemeinschaft medikamentoese Tumortherapie 24
Early research (Phase 1)Active Not RecruitingNCT04231877
What this trial is testing

Polatuzumab Vedotin and Combination Chemotherapy With or Without Glofitamab for the Treatment of Untreated Aggressive Large B-cell Lymphoma

Who this might be right for
Aggressive Non-Hodgkin LymphomaALK-Positive Large B-Cell LymphomaDiffuse Large B-Cell Lymphoma, Not Otherwise Specified+6 more
University of Washington 56
Testing effectiveness (Phase 2)UnknownNCT00054951
What this trial is testing

Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads

Who this might be right for
Hepatocellular Carcinoma
FeRx 30
Testing effectiveness (Phase 2)Ended earlyNCT03646123
What this trial is testing

Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Seagen Inc. 255
Testing effectiveness (Phase 2)Study completedNCT00407888
What this trial is testing

Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With Surgery

Who this might be right for
Estrogen Receptor-positive Breast CancerHER2-positive Breast CancerStage IA Breast Cancer+6 more
University of Washington 60
Next Page